Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 78 entries
View as:

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

Phase: N/A Priority: Normal
NCT ID: NCT03051087 Org: User:
Start: 10/31/16 End: 03/31/18 Due: 03/31/19

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

Phase: N/A Priority: Normal
NCT ID: NCT01145950 Org: User:
Start: 06/30/10 End: 01/31/11 Due: 01/31/12

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Phase: N/A Priority: Normal
NCT ID: NCT01659775 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT01019772 Org: User:
Start: 07/31/07 End: 08/31/08 Due: 08/31/09

Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)

Phase: N/A Priority: Normal
NCT ID: NCT01879007 Org: User:
Start: 01/31/06 End: - Due: -

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Phase: N/A Priority: Normal
NCT ID: NCT02670018 Org: User:
Start: 08/31/15 End: 03/31/16 Due: 03/31/17

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01896739 Org: User:
Start: 08/31/09 End: 11/30/11 Due: 11/30/12

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01928628 Org: User:
Start: 05/31/12 End: - Due: -

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Phase: N/A Priority: Normal
NCT ID: NCT01251133 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02892812 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

Phase: N/A Priority: Normal
NCT ID: NCT02042170 Org: User:
Start: 02/28/14 End: 03/31/15 Due: 03/31/16

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01602003 Org: User:
Start: 12/31/09 End: 05/31/12 Due: 05/31/13

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Phase: N/A Priority: Normal
NCT ID: NCT01725620 Org: User:
Start: 11/30/12 End: 04/30/14 Due: 04/30/15

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01768455 Org: User:
Start: 02/28/13 End: - Due: -

Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01601990 Org: User:
Start: 12/31/09 End: 11/30/11 Due: 11/30/12

Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

Phase: N/A Priority: Normal
NCT ID: NCT02119780 Org: User:
Start: 05/31/14 End: - Due: -

Treatment of Children With Insufficient Secretion of Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT00271518 Org: User:
Start: 09/30/05 End: - Due: -

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01823133 Org: User:
Start: 04/30/13 End: 08/31/13 Due: 08/31/14

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Phase: N/A Priority: Normal
NCT ID: NCT02831361 Org: User:
Start: 10/17/16 End: 02/08/18 Due: 02/08/19

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01122251 Org: User:
Start: 12/31/09 End: 07/31/10 Due: 07/31/11

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01426906 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Study of LC23-1306 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01526577 Org: User:
Start: 03/31/12 End: 08/31/13 Due: 08/31/14

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Phase: N/A Priority: Normal
NCT ID: NCT01605331 Org: User:
Start: 12/31/09 End: 09/30/10 Due: 09/30/11

Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Phase: N/A Priority: Normal
NCT ID: NCT02770664 Org: User:
Start: 04/30/16 End: - Due: -

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01737424 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14